Symbion Entered into an Agreement with Thermo Scientific’s Informatics Business
News Nov 07, 2012
Symbion Systems, Inc. has announced that it has entered into an agreement with the Informatics Business of Thermo Fisher Scientific under which Thermo Fisher will become a distributor of Symbion’s line of software products.
The products will be marketed in conjunction with the GRAMS spectroscopy software suite, broadening Thermo Fisher’s already substantial family of products for visualizing, processing, and managing spectroscopic data.
“The Thermo Fisher agreement provides Symbion with a new highly respected distributor with high visibility in the spectroscopic community,” said Dr. W. Michael Doyle, CEO of Symbion Systems.
Dr. Doyle continued, “It will complement Symbion’s established distributions channels including the direct marketing of its products to instrument manufacturers, systems integrators and end users.”
Symbion-DX and RX provide standardized platforms for controlling a wide range of spectrometers and other analytical instruments. In addition, they feature extensive data manipulation and application development capabilities as well as the ability to communicate with numerous third party programs, and enterprise-wide data systems.
These programs streamline the development of comprehensive analytical methods encompassing instrument and sample system control, data analysis, process trending, database archiving, and reporting to enterprise-wide data systems.
Each method is permanently stored in the underlying Oracle™ database and is under full version control, compliant with 21 CFR Part 11.
Once validated, a method can be recalled from the database and downloaded for deployment at multiple instrumentation locations.
In short, Symbion-DX and RX provide all of the instrumentation capabilities required for on-line process analysis and integration into systems for process analytical technology (PAT).
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE
Gravitational Lensing Identifies Farthest Galaxy YetNews
An intensive survey deep into the universe by NASA's Hubble and Spitzer space telescopes has yielded the proverbial needle-in-a-haystack: the farthest galaxy yet seen in an image that has been stretched and amplified by a phenomenon called gravitational lensing.READ MORE